OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 2. Antimicrobial susceptibility of carbapenem-non-susceptible Pseudomonas aeruginosa isolates according to isolation hospital
Antimicrobial agent Non-susceptible isolates, N (%)
KNUH (N=50) GNUH (N=45) JNUH (N=60) Total (N=155)
Amikacin 27 (54.0)* 24 (53.3) 26 (43.3) 77 (49.7)
Gentamicin 37 (74.0) 31 (68.9) 46 (76.7)* 114 (73.5)
Tobramycin 32 (64.0)* 23 (51.1) 34 (56.7) 89 (57.4)
Piperacillin 45 (90.0) 42 (93.3)* 56 (93.3)* 143 (92.3)
Piperacillin/tazobactam 45 (90.0) 40 (88.9) 56 (93.3)* 141 (91.0)
Cefepime 39 (78.0) 37 (82.2)* 45 (75.0) 121 (78.1)
Ceftazidime 40 (80.0) 34 (75.6) 50 (83.3)* 124 (80.0)
Imipenem 50 (100)* 43 (95.6) 60 (100)* 153 (98.7)
Meropenem 48 (96.0)* 42 (93.3) 55 (91.7) 145 (93.5)
Aztreonam 40 (80.0)* 30 (66.7) 44 (73.3) 114 (73.5)
Ciprofloxacin 38 (76.0) 38 (84.4) 53 (88.3)* 129 (83.2)

*The highest resistance rate among the three hospitals.

Abbreviations: KNUH, Kyungpook National University Hospital; GNUH, Gyeongsang National University Hospital; JNUH, Jeonbuk National University Hospital.

Ann Lab Med 2024;44:410~417 https://doi.org/10.3343/alm.2023.0369

© Ann Lab Med